GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DXS International PLC (AQSE:DXSP) » Definitions » Intrinsic Value: Projected FCF

DXS International (AQSE:DXSP) Intrinsic Value: Projected FCF : £0.03 (As of May. 24, 2024)


View and export this data going back to 2008. Start your Free Trial

What is DXS International Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-24), DXS International's Intrinsic Value: Projected FCF is £0.03. The stock price of DXS International is £0.0135. Therefore, DXS International's Price-to-Intrinsic-Value-Projected-FCF of today is 0.5.

The historical rank and industry rank for DXS International's Intrinsic Value: Projected FCF or its related term are showing as below:

AQSE:DXSP' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.45   Med: 2.3   Max: 3
Current: 0.45

During the past 9 years, the highest Price-to-Intrinsic-Value-Projected-FCF of DXS International was 3.00. The lowest was 0.45. And the median was 2.30.

AQSE:DXSP's Price-to-Projected-FCF is ranked better than
83.97% of 312 companies
in the Healthcare Providers & Services industry
Industry Median: 1.285 vs AQSE:DXSP: 0.45

DXS International Intrinsic Value: Projected FCF Historical Data

The historical data trend for DXS International's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DXS International Intrinsic Value: Projected FCF Chart

DXS International Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only - - 0.03 0.05 0.03

DXS International Semi-Annual Data
Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only - - 0.03 0.05 0.03

Competitive Comparison of DXS International's Intrinsic Value: Projected FCF

For the Health Information Services subindustry, DXS International's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DXS International's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DXS International's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where DXS International's Price-to-Projected-FCF falls into.



DXS International Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



DXS International  (AQSE:DXSP) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

DXS International's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.0135/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DXS International Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of DXS International's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


DXS International (AQSE:DXSP) Business Description

Traded in Other Exchanges
N/A
Address
119 St Mary’s Road, Market Harborough, London, Leicestershire, GBR, LE16 7DT
DXS International PLC is engaged in the development and distribution of clinical decision support, content, and technology to general practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its products include CompleteCare, ExpertCare, and MyVytalCare.

DXS International (AQSE:DXSP) Headlines

No Headlines